DAY ONE BIOPHARMACEUTICALS I's ticker is DAWN and the CUSIP is 23954D109. A total of 108 filers reported holding DAY ONE BIOPHARMACEUTICALS I in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $20,198,813 | -29.3% | 1,646,195 | -31.2% | 0.00% | -33.3% |
| Q2 2023 | $28,566,725 | -6.4% | 2,392,523 | +4.8% | 0.01% | -14.3% |
| Q1 2023 | $30,528,203 | -19.8% | 2,283,336 | +29.1% | 0.01% | -22.2% |
| Q4 2022 | $38,049,556 | +10.1% | 1,768,102 | +2.5% | 0.01% | +12.5% |
| Q3 2022 | $34,555,000 | +1.9% | 1,725,142 | -8.9% | 0.01% | 0.0% |
| Q2 2022 | $33,912,000 | +10839.4% | 1,894,537 | +5969.9% | 0.01% | – |
| Q1 2022 | $310,000 | -25.1% | 31,212 | +27.2% | 0.00% | – |
| Q4 2021 | $414,000 | +56.8% | 24,546 | +111.7% | 0.00% | – |
| Q2 2021 | $264,000 | – | 11,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 6,964,301 | $139,495,000 | 56.26% |
| PATHWAY CAPITAL MANAGEMENT, LP | 403,127 | $8,075,000 | 25.88% |
| Atlas Venture Life Science Advisors, LLC | 8,169,171 | $163,628,000 | 18.06% |
| RA Capital Management | 7,040,622 | $141,024,000 | 3.01% |
| COMMODORE CAPITAL LP | 739,661 | $14,815,000 | 2.38% |
| Nicholas Investment Partners, LP | 757,407 | $15,171,000 | 1.41% |
| Boxer Capital, LLC | 1,189,943 | $23,835,000 | 1.34% |
| Parkman Healthcare Partners LLC | 212,191 | $4,250,000 | 1.21% |
| TANG CAPITAL MANAGEMENT LLC | 400,000 | $8,012,000 | 0.98% |
| Samsara BioCapital, LLC | 196,425 | $3,934,000 | 0.92% |